Glycine

insulin ; Homo sapiens







109 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35052658 GlyNAC (Glycine and N-Acetylcysteine) Supplementation Improves Impaired Mitochondrial Fuel Oxidation and Lowers Insulin Resistance in Patients with Type 2 Diabetes: Results of a Pilot Study. 2022 Jan 13 1
2 35460232 Genetic variants in ALDH1L1 and GLDC influence serine to glycine ratio in Hispanic children. 2022 Apr 23 1
3 33783984 Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial. 2021 Mar 1
4 34044180 Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street. 2021 Oct 1
5 34084151 Nuclear Magnetic Resonance Derived Biomarkers for Evaluating Cardiometabolic Risk in Youth and Young Adults Across the Spectrum of Glucose Tolerance. 2021 1
6 34449768 Association of IRS1 (Gly972Arg) and IRS2 (Gly1057Asp) genes polymorphisms with OSA and NAFLD in Asian Indians. 2021 1
7 34587244 GlyNAC Supplementation Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Aging Hallmarks, Metabolic Defects, Muscle Strength, Cognitive Decline, and Body Composition: Implications for Healthy Aging. 2021 Dec 3 1
8 34593560 Selective Inhibition of N-Methyl-d-aspartate Receptors with GluN2B Subunit Protects β Cells against Stress-Induced Apoptotic Cell Death. 2021 Nov 1
9 32093879 An association between glycine and insulin levels is observed in patients with pulmonary tuberculosis and type 2 diabetes. 2020 Oct 6
10 32271092 Long-term safety and effectiveness of biosimilar insulin glargine in Japanese patients with diabetes mellitus in routine clinical practice: results of a post-marketing safety study. 2020 Jun 1
11 32429590 Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance. 2020 May 17 1
12 33007928 Supplementing Glycine and N-acetylcysteine (GlyNAC) in Aging HIV Patients Improves Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Endothelial Dysfunction, Insulin Resistance, Genotoxicity, Strength, and Cognition: Results of an Open-Label Clinical Trial. 2020 Sep 30 1
13 33030354 Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study. 2020 Dec 3
14 30604098 Functionality of an absolutely conserved glycine residue in the chimeric relaxin family peptide R3/I5. 2019 Apr 3
15 30837465 Assessing the causal association of glycine with risk of cardio-metabolic diseases. 2019 Mar 5 2
16 31104335 Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer's risk factors among 1,111 cohort participants. 2019 Sep 1
17 31908508 Detection of Secondary Metabolites as Biomarkers for the Early Diagnosis and Prevention of Type 2 Diabetes. 2019 1
18 32003208 Associations of irs-1 polymorphism with various components of the metabolic syndrome in hypertensive patients 2019 Aug 31 1
19 29094215 Insulin resistance and glycine metabolism in humans. 2018 Jan 2
20 29239245 Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes. 2018 Jan 1
21 29916244 The Role of Water in the Stability of Wild-type and Mutant Insulin Dimers. 2018 Jul 19 1
22 26614892 Expression of recombinant human bifunctional peptidylglycine α-amidating monooxygenase in CHO cells and its use for insulin analogue modification. 2016 Mar 1
23 27207556 A Glycine-Insulin Autocrine Feedback Loop Enhances Insulin Secretion From Human β-Cells and Is Impaired in Type 2 Diabetes. 2016 Aug 5
24 25041275 Insulin glargine metabolite 21(A) -Gly-human insulin (M1) is the principal component circulating in the plasma of young children with type 1 diabetes: results from the PRESCHOOL study. 2015 Jun 4
25 25582325 Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE. 2015 Jan 8 1
26 25821801 Elevated serum levels of cysteine and tyrosine: early biomarkers in asymptomatic adults at increased risk of developing metabolic syndrome. 2015 1
27 26139616 Large-Scale Refolding and Enzyme Reaction of Human Preproinsulin for Production of Human Insulin. 2015 Oct 1
28 24130332 BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans. 2014 Feb 1
29 24571126 Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml. 2014 Sep 2
30 25002580 Deciphering a molecular mechanism of neonatal diabetes mellitus by the chemical synthesis of a protein diastereomer, [D-AlaB8]human proinsulin. 2014 Aug 22 3
31 25120925 Interaction of ingested leucine with glycine on insulin and glucose concentrations. 2014 1
32 23378610 Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes. 2013 Jun 1
33 23466546 Preparation of poly(hydroxyethyl methacrylate) cryogels containing L-histidine for insulin recognition. 2013 Jul 1 1
34 24391874 Serum glycine is associated with regional body fat and insulin resistance in functionally-limited older adults. 2013 2
35 21537880 Taurine in adipocytes prevents insulin-mediated H2O2 generation and activates Pka and lipolysis. 2012 May 1
36 21674205 Controlling the aggregation and rate of release in order to improve insulin formulation: molecular dynamics study of full-length insulin amyloid oligomer models. 2012 Mar 1
37 23056045 Arginine 16 Glycine Polymorphism in β2-Adrenergic Receptor Gene is Associated with Obesity, Hyperlipidemia, Hyperleptinemia, and Insulin Resistance in Saudis. 2012 1
38 23093664 Plasma exposure to insulin glargine and its metabolites M1 and M2 after subcutaneous injection of therapeutic and supratherapeutic doses of glargine in subjects with type 1 diabetes. 2012 Dec 8
39 21668335 Basal insulin treatment in type 2 diabetes. 2011 Jun 1
40 21764223 Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease. 2011 Oct 1
41 21936798 Cysteine residues as catalysts for covalent peptide and protein modification: a role for thiyl radicals? 2011 Oct 1
42 19010062 Insulin secretion and sensitivity in Bangladeshi prediabetic subjects. 2010 Jan-Feb 1
43 20130411 Peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha gene polymorphisms in Korean women with polycystic ovary syndrome. 2010 1
44 20209060 In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites. 2010 Mar 4 1
45 20522590 Functional variants in MBL2 are associated with type 2 diabetes and pre-diabetes traits in Pima Indians and the old order Amish. 2010 Aug 1
46 17972239 Metabolic characteristics of glucose intolerance: the critical role of obesity. 2008 Feb 1
47 18029081 Structural interpretation of reduced insulin activity as seen in the crystal structure of human Arg-insulin. 2008 Mar 1
48 18583466 Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization. 2008 Sep 3
49 17308032 Insulin increases the potency of glycine at ionotropic glycine receptors. 2007 May 4
50 17512307 Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. 2007 Jun 4